Research Article
Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients
Table 1
Demographic and perioperative data on 34 patients treated with cytoreductive surgery and heated intraperitoneal chemotherapy with melphalan.
| Gender | | Male | 14 | Female | 20 | Age (mean) | 46.1 | Primary diagnosis | | Appendix cancer | 23 | Mesothelioma | 6 | Colon cancer | 2 | Ovarian cancer | 2 | Urachal cancer | 1 | Peritoneal cancer index (PCI) | | Mean | 21 | Range | 4–39 | Completeness of cytoreduction score | | CC-1 | 21 | CC-2 | 7 | CC-3 | 6 | Dose of melphalan | | 50 mg/m2 | 5 | 60 mg/m2 | 17 | 70 mg/m2 | 10 |
|
|